NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches. AL resident?

Legislation 239

Legislation Patients Decriminalization Access 239

NORML

JANUARY 11, 2019

Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes. The measure would permit patients to grow up to nine cannabis plants in a locked, enclosed facility, and to possess up to three ounces of home-grown medical cannabis. NH resident?

Legislation 196

Legislation Decriminalization Hemp Patients 196

United Patients Group

APRIL 11, 2023

Doctor of Dental Medicine Dental professionals play a critical role in maintaining the overall health of patients. They diagnose and treat oral diseases, perform procedures such as tooth extraction, root canal therapy, and dental implants, and educate patients on how to maintain proper oral hygiene.

Education 52

Education Research and Development Therapy Programs 52

MMJ Recs

JANUARY 20, 2024

Maryland, a trailblazer in progressive healthcare policies, has been part of this trend. With a nuanced approach to medical marijuana laws, the state has embarked on a journey that seeks to balance patient well-being, regulatory oversight, and societal concerns. As of the latest guidelines, patients are allowed to possess up to 1.5

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

MAY 18, 2022

With few solutions in sight, there is a growing body of evidence that suggests that psychedelic-assisted therapy could provide a breakthrough in treating countless mental health ailments, such as depression, substance abuse disorders, and PTSD. The clinical evidence for psychedelic assisted therapy is accumulating.

Research and Development 52

Research and Development Therapy Treatment Policy 52

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.

Legislation 162

Legislation Decriminalization Access Patients 162

NORML

MARCH 14, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 186

Legislation Access Patients THC 186

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

APRIL 12, 2019

I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3%

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

AUGUST 18, 2021

Employers are not prohibited from establishing or enforcing drug testing policies, including drug-free workplace policies, or requiring a worker to disclose that they are a medical marijuana card holder. The Hall Act expressly does not allow for the use of cannabis products that are smoked or vaped, baked goods, or candies. New Mexico.

Legislation 105

Legislation Legalization Marijuana Recreational 105

NORML

MARCH 22, 2019

Governor Ron DeSantis (R) of Florida signed legislation into law to restore patients’ right to smoke medical cannabis. Governor Ralph Northam (D) of Virginia signed legislation into law that will allow medical cannabis oil to be administered to patients on school property. CA resident? DE resident? DE resident? HI resident?

Legislation 135

Legislation Hemp Patients Compliance 135

NORML

MARCH 8, 2019

North Dakota’s first medical cannabis dispensary opened its doors last week in Fargo; and registered out-of-state medical cannabis patients will now be able to access their medicine while visiting Hawaii. House Bill 19-1028 would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder.

Legislation 168

Legislation Patients Access Seed-To-Sale 168

NORML

FEBRUARY 15, 2019

” At a more local level, the decriminalization policy in Dayton, Ohio went into effect this week. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. The bill now goes to the Appropriations Committee. GA resident? MN resident?

Legislation 160

Legislation Hemp Compliance Compliance 160

Cannabis Law Report

FEBRUARY 28, 2022

Moreover, because Indigenous communities pioneered many aspects of modern psychedelic therapies, their patenting by Western corporations may promote biopiracy, the exploitation of Indigenous knowledge without compensation. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study , 27 NATURE MED.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

NORML

FEBRUARY 22, 2019

Passage of this legislation is important because the Arizona Court of Appeals recently ruled that patients who rely on these products are not protected under the law and could face felony penalties for simply using their medicine. Update : HB 2149 was approved by the Public Safety Committee on 2/20. AZ resident? AZ resident?

Legislation 177

Legislation Hemp Compliance Compliance 177

Veriheal

OCTOBER 29, 2020

Of that, the American National Institute on Drug Abuse (NIDA) has invested just over $1 billion and has allocated far more money to researching cannabis misuse and the negative effects of consuming cannabis and its compounds as a form of therapy. Scenario 1: Accuracy. Scenario 4: Industry Death. Research is necessary to afford certainty. .

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

Cannabis Law Report

DECEMBER 7, 2021

The DEA hopes such regulations will impose uniformity and standardization to a healthcare industry that increasingly draws on technology and multistate geographic footprints to reduce costs, increase patient access, and drive convenient delivery of medications to consumers. EDGE Policy Conference | American Telemedicine Association.

DEA 52

DEA Patients Therapy Access 52

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. More recently, MDMA therapy has inched closer to FDA approval. 10] In the meantime, FDA has approved some requests for compassionate use. [11].

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Specifically, the agency fears that.

CBD 90

CBD Safety Topical Food 90

Cannabis Law Report

JUNE 25, 2021

This appointment is driven by the expansion of Awakn’s psychedelic drug and therapy development pipeline targeting Addiction. Nutt will lead Awakn’s neuroscience research of psychedelic compounds for treating a broad range of addictions where the consequences for the patient, their family, and society are at present most severe.

Research and Development 66

Research and Development Therapy Medicine Pets 66

CannaMD

SEPTEMBER 10, 2020

Is it safe to continue cannabis-based therapies during pregnancy? This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

JANUARY 23, 2022

GVHD affects a significant portion of transplant patients, anywhere between 30% and 70% of patients depending on how closely the donor’s tissue matches with the patient. The team recruited 48 Patients with leukaemia or myelodysplastic syndrome. No grades III to IV toxicities were attributed to CBD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease. www.igcinc.us , www.igcpharma.com.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

NORML

MAY 3, 2019

Governor Jay Inslee (D) of Washington signed legislation into law allowing medical cannabis to be accessed by patients on school grounds, and separate legislation allowing the production of industrial hemp in accordance with new federal hemp regulations. Welcome to the latest edition of NORML’s Weekly Legislative Roundup! CO resident?

Legislation 162

Legislation Decriminalization Hemp Patients 162

CannaMD

DECEMBER 9, 2020

Little time will be devoted to opening sections which cover well-documented topics such as historic and current cannabis use, definitions, formulations, pharmacokinetics, pharmacodynamics, and policies on use. 1 hour after ingestion with a peak effect within 3 to 4 hours; thus, they should be particularly careful about stacking oral doses.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

JULY 30, 2019

With it, the national research and policy landscape is rapidly changing as well. The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.” Pain Foundation.

Marijuana 40

Marijuana Education Patients Research and Development 40

Cannabis Law Report

MARCH 19, 2020

The patchwork of state laws and regulations is a concern for the CBD industry, as well as patient groups. This analysis is intended to inform FDA’s development of an enforcement discretion policy and evaluation of hemp-derived CBD in food and dietary supplements. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Cannabis Law Report

JUNE 16, 2021

With increased capacity to screen patients, on a genetic basis, for underlying psychiatric disorders prior to undertaking PAP, Entheon is furthering its commitment toward safety and predictability in psychedelic therapies while aggregating data that can be used to determine which psychedelic molecules are best-suited for a particular patient.”

Research and Development 105

Research and Development Data Conditions Events 105

NORML

MARCH 29, 2019

Governor Gary Herbert (R) of Utah signed legislation into law that strengthens protections for medical cannabis patients and further improves upon the state’s new medical cannabis access program. Legislation is pending, Senate Bill 223, to allow medical cannabis to be administered to patients at school. CA resident? DE resident?

Legislation 165

Legislation Decriminalization Hemp Patients 165

Cannabis Law Report

MAY 28, 2019

Many patients with PTSD report having flashbacks or intrusive thoughts which result in involuntarily re-living past traumatic events. 5] The most common treatments for PTSD are cognitive behavioral therapy or selective serotonin uptake inhibitors (SSRIs) including Paxil, Zoloft, and Prozac. [6] Currently Serving Military.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Canna Law Blog

MARCH 4, 2020

In an even larger trend, the health care provider community seems to be exploring various alternative therapies and emerging medicines to improve quality of care. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

The Cannigma

MAY 21, 2021

It’s an interesting thing to realize that you’ve tried and experimented with all the ‘accepted therapies’ and they’ve been damaging,” Simon said on The Cannabis Enigma podcast, “and the one that’s been most effective and supportive has been the most demonized.”.

Education 130

Education Programs Research and Development Cannabis 130

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. The review, however, did not cover patient access to medicinal cannabis. The states’ situation varies substantially.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. At 36, MAPS is now older than I was when I started MAPS at age 32.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Sensi Seeds

NOVEMBER 28, 2018

Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78